Cargando…

DNA methylation markers for oral pre-cancer progression: A critical review

Although oral cancers are generally preceded by a well-established pre-cancerous stage, there is a lack of well-defined clinical and morphological criteria to detect and signal progression from pre-cancer to malignant tumours. We conducted a critical review to summarize the evidence regarding aberra...

Descripción completa

Detalles Bibliográficos
Autores principales: Shridhar, Krithiga, Walia, Gagandeep Kaur, Aggarwal, Aastha, Gulati, Smriti, Geetha, A.V., Prabhakaran, Dorairaj, Dhillon, Preet K., Rajaraman, Preetha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788701/
https://www.ncbi.nlm.nih.gov/pubmed/26690652
http://dx.doi.org/10.1016/j.oraloncology.2015.11.012
_version_ 1782420755490799616
author Shridhar, Krithiga
Walia, Gagandeep Kaur
Aggarwal, Aastha
Gulati, Smriti
Geetha, A.V.
Prabhakaran, Dorairaj
Dhillon, Preet K.
Rajaraman, Preetha
author_facet Shridhar, Krithiga
Walia, Gagandeep Kaur
Aggarwal, Aastha
Gulati, Smriti
Geetha, A.V.
Prabhakaran, Dorairaj
Dhillon, Preet K.
Rajaraman, Preetha
author_sort Shridhar, Krithiga
collection PubMed
description Although oral cancers are generally preceded by a well-established pre-cancerous stage, there is a lack of well-defined clinical and morphological criteria to detect and signal progression from pre-cancer to malignant tumours. We conducted a critical review to summarize the evidence regarding aberrant DNA methylation patterns as a potential diagnostic biomarker predicting progression. We identified all relevant human studies published in English prior to 30th April 2015 that examined DNA methylation (%) in oral pre-cancer by searching PubMed, Web-of-Science and Embase databases using combined key-searches. Twenty-one studies (18-cross-sectional; 3-longitudinal) were eligible for inclusion in the review, with sample sizes ranging from 4 to 156 affected cases. Eligible studies examined promoter region hyper-methylation of tumour suppressor genes in pathways including cell-cycle-control (n = 15), DNA-repair (n = 7), cell-cycle-signalling (n = 4) and apoptosis (n = 3). Hyper-methylated loci reported in three or more studies included p16, p14, MGMT and DAPK. Two longitudinal studies reported greater p16 hyper-methylation in pre-cancerous lesions transformed to malignancy compared to lesions that regressed (57–63.6% versus 8–32.1%; p < 0.01). The one study that explored epigenome-wide methylation patterns reported three novel hyper-methylated loci (TRHDE; ZNF454; KCNAB3). The majority of reviewed studies were small, cross-sectional studies with poorly defined control groups and lacking validation. Whilst limitations in sample size and study design preclude definitive conclusions, current evidence suggests a potential utility of DNA methylation patterns as a diagnostic biomarker for oral pre-cancer progression. Robust studies such as large epigenome-wide methylation explorations of oral pre-cancer with longitudinal tracking are needed to validate the currently reported signals and identify new risk-loci and the biological pathways of disease progression.
format Online
Article
Text
id pubmed-4788701
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-47887012016-03-22 DNA methylation markers for oral pre-cancer progression: A critical review Shridhar, Krithiga Walia, Gagandeep Kaur Aggarwal, Aastha Gulati, Smriti Geetha, A.V. Prabhakaran, Dorairaj Dhillon, Preet K. Rajaraman, Preetha Oral Oncol Review Although oral cancers are generally preceded by a well-established pre-cancerous stage, there is a lack of well-defined clinical and morphological criteria to detect and signal progression from pre-cancer to malignant tumours. We conducted a critical review to summarize the evidence regarding aberrant DNA methylation patterns as a potential diagnostic biomarker predicting progression. We identified all relevant human studies published in English prior to 30th April 2015 that examined DNA methylation (%) in oral pre-cancer by searching PubMed, Web-of-Science and Embase databases using combined key-searches. Twenty-one studies (18-cross-sectional; 3-longitudinal) were eligible for inclusion in the review, with sample sizes ranging from 4 to 156 affected cases. Eligible studies examined promoter region hyper-methylation of tumour suppressor genes in pathways including cell-cycle-control (n = 15), DNA-repair (n = 7), cell-cycle-signalling (n = 4) and apoptosis (n = 3). Hyper-methylated loci reported in three or more studies included p16, p14, MGMT and DAPK. Two longitudinal studies reported greater p16 hyper-methylation in pre-cancerous lesions transformed to malignancy compared to lesions that regressed (57–63.6% versus 8–32.1%; p < 0.01). The one study that explored epigenome-wide methylation patterns reported three novel hyper-methylated loci (TRHDE; ZNF454; KCNAB3). The majority of reviewed studies were small, cross-sectional studies with poorly defined control groups and lacking validation. Whilst limitations in sample size and study design preclude definitive conclusions, current evidence suggests a potential utility of DNA methylation patterns as a diagnostic biomarker for oral pre-cancer progression. Robust studies such as large epigenome-wide methylation explorations of oral pre-cancer with longitudinal tracking are needed to validate the currently reported signals and identify new risk-loci and the biological pathways of disease progression. Elsevier 2016-02 /pmc/articles/PMC4788701/ /pubmed/26690652 http://dx.doi.org/10.1016/j.oraloncology.2015.11.012 Text en © 2015 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review
Shridhar, Krithiga
Walia, Gagandeep Kaur
Aggarwal, Aastha
Gulati, Smriti
Geetha, A.V.
Prabhakaran, Dorairaj
Dhillon, Preet K.
Rajaraman, Preetha
DNA methylation markers for oral pre-cancer progression: A critical review
title DNA methylation markers for oral pre-cancer progression: A critical review
title_full DNA methylation markers for oral pre-cancer progression: A critical review
title_fullStr DNA methylation markers for oral pre-cancer progression: A critical review
title_full_unstemmed DNA methylation markers for oral pre-cancer progression: A critical review
title_short DNA methylation markers for oral pre-cancer progression: A critical review
title_sort dna methylation markers for oral pre-cancer progression: a critical review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788701/
https://www.ncbi.nlm.nih.gov/pubmed/26690652
http://dx.doi.org/10.1016/j.oraloncology.2015.11.012
work_keys_str_mv AT shridharkrithiga dnamethylationmarkersfororalprecancerprogressionacriticalreview
AT waliagagandeepkaur dnamethylationmarkersfororalprecancerprogressionacriticalreview
AT aggarwalaastha dnamethylationmarkersfororalprecancerprogressionacriticalreview
AT gulatismriti dnamethylationmarkersfororalprecancerprogressionacriticalreview
AT geethaav dnamethylationmarkersfororalprecancerprogressionacriticalreview
AT prabhakarandorairaj dnamethylationmarkersfororalprecancerprogressionacriticalreview
AT dhillonpreetk dnamethylationmarkersfororalprecancerprogressionacriticalreview
AT rajaramanpreetha dnamethylationmarkersfororalprecancerprogressionacriticalreview